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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYMaintenance and differentiation of hematopoietic stem cells (HSCs) is regulated through cell-autonomous and non-cell-autonomous
mechanisms within specialized bone marrow microenvironments. Recent evidence demonstrates that signaling by HIF-1a contributes
to cell-autonomous regulation of HSC maintenance. By investigating the role of HIF factors in bone marrowmesenchymal progenitors,
we found thatmurine endostealmesenchymal progenitors express high levels of HIF-1a andHIF-2a and proliferate preferentially in hyp-
oxic conditions ex vivo. Inactivation of either HIF-1a or HIF-2a dramatically affects their phenotype, propagation, and differentiation.
Also, downregulation of HIF factors provokes an increase in interferon-responsive genes and triggers expansion and differentiation of
hematopoietic progenitors by a STAT1-mediated mechanism. Interestingly, in conditions of demand-driven hematopoiesis HIF factors
are specifically downregulated in mesenchymal progenitors in vivo. In conclusion, our findings indicate that HIF factors also regulate
hematopoiesis non-cell-autonomously by preventing activation of a latent program in mesenchymal progenitors that promotes
hematopoiesis.INTRODUCTION
Hematopoiesis is a tightly regulated process orchestrated
by cell-autonomous and non-cell-autonomous signals
emanating from a variety of cell types within specialized
bone marrow (BM) microenvironments (Wang and
Wagers, 2011; Frenette et al., 2013). Coordinated signals
instruct hematopoietic stem cells (HSCs) to maintain their
undifferentiated status or to commit and differentiate into
mature hematopoietic cells (Kiel and Morrison, 2008; Wil-
son and Trumpp, 2006).
A number of recent reports suggest that signaling by
hypoxia-inducible transcription factors (HIFs) regulate
HSC maintenance in a cell-autonomous manner. HIF fac-
tors are heterodimeric transcription factors composed of
a and b subunits: the b subunit (ARNT) is constitutively
expressed, whereas the a subunit is degraded through an
oxygen-dependent mechanism and is stabilized at low
oxygen concentrations (Schofield and Ratcliffe, 2004).
Three a subunits have been identified: HIF-1a, HIF-2a,
and HIF-3a, with HIF-1a and HIF-2a being the most exten-
sively characterized (Keith et al., 2012). Despite sharing a
high degree of sequence identity, HIF-1a and HIF-2a are
not redundant, because they are expressed at least partly
in a tissue-specific manner and regulate a number of
unique target genes (Ratcliffe, 2007; Keith et al., 2012). In
hypoxic conditions, HIF transcription factors trigger a794 Stem Cell Reports j Vol. 2 j 794–809 j June 3, 2014 j ª2014 The Authorvariety of adaptive responses that include induction of
anaerobic metabolism, cell migration, and neo-angiogen-
esis (Semenza, 2003). More recently, HIF factors are being
increasingly implicated in regulating stem cells homeosta-
sis (Mohyeldin et al., 2010; Suda et al., 2011), particularly
in the hematopoietic system where HIF-1a is expressed in
HSC (Takubo et al., 2010) and promotes HSC maintenance
by enforcing a glycolytic metabolic state (Takubo et al.,
2013).
Quiescent, long-term repopulating HSC (LT-HSC) are
believed to reside predominantly in periendosteal areas of
the BM characterized by low oxygen levels (Mohyeldin
et al., 2010; Suda et al., 2011; Eliasson and Jo¨nsson,
2010). Moreover, it is recently being suggested that HSC
and hematopoietic progenitorsmay exhibit a hypoxic state
and express high levels of HIF-1a also through oxygen-
independent mechanisms (Nombela-Arrieta et al., 2013).
Different cell populations reside in close proximity to
HSC in the BM and participate to the regulation of HSC
maintenance and differentiation (Wang and Wagers,
2011). Within these cell types, a number of mesenchymal
progenitors are being described as important non-cell-
autonomous regulators of HSC maintenance (Wang and
Wagers, 2011). Mesenchymal progenitors are functionally
defined as clonogenic populations that can differentiate to-
ward mesenchymal lineages adipocytes, osteoblasts, and
chondrocytes ex vivo (Uccelli et al., 2008; Nombela-Arrietas
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SCA-1 and PDGFRa (from now on referred to as PaS+ cells)
localize to the perivascular spaces of endosteal BM (Mori-
kawa et al., 2009; Nakamura et al., 2010) and are described
as important regulators of HSC maintenance (Nakamura
et al., 2010; Ding and Morrison, 2013; Greenbaum et al.,
2013).
Here, we demonstrate that similarly toHSC, PaS+ cells are
characterized by a hypoxic gene expression profile, as
measured by expression of HIF-1a, HIF-2a, and HIF-target
genes and have increased capacity to proliferate and form
colonies in hypoxic conditions ex vivo. We find that
expression of HIF-1a and HIF-2a in PaS+ progenitors is
necessary to maintain their colony-forming capacity,
differentiation competence and phenotype. Moreover,
expression of HIF factors in PaS+ progenitors is necessary
to promote non-cell-autonomous regulation of hemato-
poiesis by a molecular mechanism involving repression
of STAT1-induced soluble factors.RESULTS
EndostealMesenchymal Progenitors Expressing SCA-1
and PDGFRa Exhibit a Hypoxic Profile
It was recently reported that HIF-1a is highly expressed in
HSC (Takubo et al., 2010). Although oxygen levels are
generally low in the BM, HIF-1a expression in HSC appears
to be regulated not only by hypoxic protein stabilization
but also by additional mechanisms, because Hif-1a is
highly expressed at the mRNA level in HSC (Takubo
et al., 2010), and HIF-1a expression is detected in HSC
residing in BM compartments characterized by different
oxygen levels (Nombela-Arrieta et al., 2013). Although
the molecular mechanisms driving HIF-1a expression in
HSC are not fully elucidated and may involve secreted fac-
tors within HSC niches, mesenchymal progenitors local-
izing in close proximity to HSC in the BM are exposed to
the same environmental conditions. Therefore, we hy-
pothesized that similarly to HSC, mesenchymal progeni-
tors may also express HIF factors and depend on hypoxia
signaling for their cell-autonomous and non-cell-autono-
mous functions.
To test this hypothesis, we focused on stromal BM cells
(CD45CD31Ter119) expressing SCA-1+ and PDGFRa+
(PaS+ cells) (Morikawa et al., 2009; Houlihan et al., 2012).
PaS+ cells are enriched in mesenchymal progenitors
because they give rise to fibroblasts colonies when plated
as single cells in vitro (colony forming unit-fibroblast assay,
or CFU-F) and differentiate into differentmesenchymal cell
types (Morikawa et al., 2009). In vivo PaS+ cells localize to
perivascular spaces at the endosteal surface of the BM (Mor-
ikawa et al., 2009; Houlihan et al., 2012; Nombela-ArrietaSteet al., 2013) and participate to non-cell-autonomous regu-
lation of hematopoiesis by inducing HSC maintenance
(Nakamura et al., 2010; Ding and Morrison, 2013; Green-
baum et al., 2013).
To assess if PaS+ cells are characterized by a hypoxic pro-
file, we measured pimonidazole incorporation and expres-
sion of HIF factors. The inner fraction of the BM (I-BM)
was collected by flushing out the BM and treating crushed
bone fragments with collagenase to isolate cells associated
with the endosteal surface (E-BM) (Grassinger et al., 2010;
Nakamura et al., 2010). The percentage of mesenchymal
cells (CD45Ter119CD31) was higher in E-BM compared
to I-BM (Figure 1A), although total mesenchymal cell
numbers were similar in the two BM fractions (Figure 1B,
left graph).Conversely, PaS+mesenchymal cellswere found
almost exclusively in E-BM (Figures 1A and1B, right graph).
To assess the hypoxic profile of endosteal mesenchymal
cells, E-BM cells were divided in pimo, pimo+, and
pimo++ based on incorporation of the hypoxic probe pimo-
nidazole (pimo; Figure 1C), and stromal cells were analyzed
within each fraction. As shown in Figure 1C (right graph),
endosteal mesenchymal cells (CD45Ter119CD31) were
found mainly in the pimo fraction (60.5%), with smaller
fractions residing in the pimo+ (16.9%) or pimo++ regions
(22.5%). On the contrary, PaS+ cells were specifically en-
riched in the pimo++ (56.5%) and pimo+ fraction (33.5%),
with only a minority of PaS+ cells being pimo (10%).
These data suggest that similarly to HSC (Nombela-Arrieta
et al., 2013), the hypoxic phenotype of mesenchymal pro-
genitors is a cell-specific phenomenon, rather than simply
depending on endosteal localization.
We next analyzed expression of HIF-1a, HIF-2a, and
bona fide HIF-target genes in PaS+ cells compared to BM
endosteal stromal cells negative for SCA-1 and PDGFRa
(PaS). PaS+ cells expressed higher mRNA levels of Hif-1a,
Hif-2a, and HIF-target genes Vegf and Glut-1, and higher
HIF-1a protein than PaS cells (Figures 1D and 1E), thus
indicating that in PaS+ cells expression of HIF-1a is regu-
lated at least in part at the transcriptional level, coherently
with a similar level of regulation in human mesenchymal
stem cells (Paloma¨ki et al., 2013). Interestingly, higher
expression of HIF-1a and HIF-2a protein (Figure 1F) and
HIF-target genes (Figure 1G) in PaS+ cells was also main-
tained after 1 week culture in hypoxic conditions, thus
indicating that even when exogenously subjected to the
same oxygen concentrations PaS+ cells maintain a stronger
hypoxia signature than PaS cells.
Suda and coworkers have demonstrated that in the
hematopoietic hierarchyHSC express highest HIF-1a levels
compared to more committed cells, while expressing low
levels of HIF-2a (Takubo et al., 2010). Interestingly, by
comparing the expression of HIF-1a and HIF-2a in BM he-
matopoietic progenitors (HPC: CD45+Lineage) and totalm Cell Reports j Vol. 2 j 794–809 j June 3, 2014 j ª2014 The Authors 795
(legend on next page)
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found that BM-SC express higher levels of both Hif factors,
with the biggest difference found inHif-2a expression (Fig-
ure S1A available online), although Hif-1a is expressed at
higher levels than Hif-2a in BM-SC (Figure S1B). Also,
HIF-1a protein levels are higher in PaS+ mesenchymal pro-
genitors than in CD45+C-KIT+SCA-1+ hematopoietic stem/
progenitor cells (Figure S1C). Taken together, these data
indicate that PaS+ cells express higher levels of HIF factors
than hematopoietic cells and other stromal cell types
residing in the same BM location and maintain a stronger
hypoxia signature also when subjected to similar oxygen
concentrations.
Mesenchymal Progenitors Expressing SCA-1 and
PDGFRa Expand Preferentially in Hypoxic Conditions
Because PaS+ cells display a hypoxic phenotype, we
analyzed their propagation and maintenance in vitro in
hypoxic conditions. When plated at single-cell dilution
(Morikawa et al., 2009; Houlihan et al., 2012) at 20% or
1% O2 for 7 days, PaS
+ cells expressed higher levels of
HIF-target genes (Figure 2A) and proliferated more effi-
ciently at 1%O2 (Figure 2B). Furthermore, the morphology
of PaS+-generated colonies and cells within these colonies
differed significantly at different O2 concentrations, with
CFU-F colonies composed of tightly adherent cells at 1%
O2, whereas cells were sparse, elongated, and detached in
20% O2 colonies (Figure 2C). In addition, hypoxic condi-
tioning contributed to maintenance of a transcriptional
profile typical of undifferentiated mesenchymal progeni-
tors (Tsai et al., 2012a; Yoon et al., 2011), such as higher
expression of the transcription factors Nanog, Oct-4, and
Sox2 (Figure 2D). These data indicate that PaS+ cells expand
preferentially in hypoxic conditions while also maintain-
ing higher expression of genes characterizing stem/progen-
itor cells.Figure 1. Mesenchymal Progenitors Expressing SCA-1 and PDGFRa
Profile
(A) Analysis of the percentage of mesenchymal cells (CD31CD45Ter
endosteal BM surface (E-BM) and in the inner BM fraction (I-BM) (n
(B) Total number of mesenchymal cells (left graph) or PaS+ cells (
mean ± SEM).
(C) Pimonidazole incorporation by endosteal BM cells. E-BM cells
(CD31CD45Ter119) or PaS+ cells were analyzed in each fraction
shown).
(D) Ex vivo RT-PCR analysis of Hif-1a, Hif-2a, Vegf, and Glut-1 mRNA l
independent experiments, mean ± SEM).
(E) Ex vivo flow cytometry analysis of HIF-1a expression in PaS+ cell
(F) Western blot analysis of HIF-1a (left blot) and IP-western blot ana
represents quantification of HIF-1a levels.
(G) RT-PCR analysis of Glut-1, Ca9, and Vegf mRNA levels in PaS cells
from two independent experiments, mean ± SEM).
See also Figure S1.
SteWe next asked whether PaS endosteal mesenchymal
cells acquired properties of mesenchymal progenitors if
cultured at low oxygen concentrations. Endosteal PaS+
and PaS stromal cells were plated at the same concentra-
tion and cultured at 1% O2. Interestingly, we found that
after 1 week in culture PaS cells acquired surface expres-
sion of both SCA-1 and PDGFRa, although at lower levels
than PaS+ cells (Figure 2E). Surprisingly, this occurred
independently of oxygen concentrations, because it also
occurred at 20% O2 (data not shown). Furthermore,
although it was previously shown that PaS cells have
limited colony-forming capacity at 20% O2 (Morikawa
et al., 2009), they formed colonies at 1% O2 (Figure 2E),
although less than PaS+ cells (Figure 2F) and with a
different morphology, being smaller and composed of
round cells (Figure 2E). Because both PaS+ and PaS cells
form colonies and express SCA-1 and PDGFRa in vitro in
hypoxia, we next analyzed the expression of genes associ-
ated with mesenchymal stem cell maintenance or dif-
ferentiation. Specifically, Oct-4 and Sox2 are expressed in
undifferentiated mesenchymal progenitors (Tsai et al.,
2012a; Yoon et al., 2011), whereas PDGF specifies commit-
ment tomesenchymal lineages (Ball et al., 2012). As shown
in Figure 2G, PaS cells express lower levels of Oct-4 and
Sox2, and higher levels of Pdgf than PaS+ cells even upon
culture in hypoxia.
Altogether, these data indicate that although hypoxic
conditioning stimulates colony-forming capacity by
endosteal mesenchymal cells, gene expression programs
and growth properties remain different in distinct mesen-
chymal cell types, thus suggesting that hypoxic condi-
tioning does not per se endorse all mesenchymal cells
with a progenitor’s profile, but possibly reinforces pro-
grams that are built in within specific cell types.
Importantly, our data also indicate that expression of
surface markers currently utilized to define mesenchymalReside at the Endosteal Surface of the BM and Display a Hypoxic
119) and PaS+ cells (CD31CD45Ter119SCA-1+PDGFRa+) at the
= 6 mice).
right graph) at endosteal or inner BM (E-BM, I-BM) (n = 6 mice,
were divided in pimo++, pimo+, and pimo and stromal cells
(one representative experiment out of two with similar results is
evels in PaS cells or in PaS+ E-BM cells (data are pooled from two
s or PaS E-BM cells (n = 3, representative analysis of one mouse).
lysis of HIF-2a (right blot) in PaS+ or PaS E-BM cells. Middle graph
or in PaS+ cells cultured for 7 days at 1% oxygen (data are pooled
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Figure 2. Mesenchymal Progenitors Expressing SCA-1 and PDGFRa Expand Preferentially in Hypoxic Conditions
(A) Relative mRNA expression of Vegf, Ca9, Glut-1, and Cxcl12 in PaS+ cells cultured for 7 days at 20% or 1% oxygen (data show one
representative experiment out of two independent experiments performed in triplicate with similar results ±SD).
(B) Number of PaS+ cells after a 7 day culture at 20% or 1% oxygen expressed as fold increase over the number of cells seeded at day 0 (data
are pooled from three independent experiments, mean ± SEM).
(legend continued on next page)
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ture, therefore suggesting that care should be taken
when defining cultured cells by the expression of these
markers.
HIF-1a and HIF-2a Regulate Expansion and
Differentiation of Mesenchymal Progenitors
To understand if HIF factors regulate proliferation and
maintenance of PaS+ mesenchymal progenitors, HIF-1a
and HIF-2a expression was downregulated ex vivo with
specific small hairpin RNAs (shRNAs) (Figures S2A and
S2B). PaS+ cells transduced with either HIF-1a or HIF-2a
shRNA showed lower CFU-F capacity and proliferation
in hypoxic conditions (Figure 3A), without undergoing
apoptosis (Figure S2C) or senescence (data not shown).
HIF silencing also affected the morphology of colonies
and colony-forming cells, with colonies formed by sparse
and elongated cells, less adherent to one another (Fig-
ure 3B), and similar to colonies formed by PaS+ cells in
20% O2 (Figure 2C). As PaS
+ cells lacking HIF-1a or HIF-
2a engaged in fewer cell-cell contacts, we investigated
whether they had increased motility. Cell migration assays
revealed that reduced expression of either HIF-1a or HIF-2a
favored PaS+ cell migration (Figure 3C).
Mesenchymal progenitors are defined as cells able to
differentiate toward the mesodermal lineages adipocytes,
osteoblasts, and chondrocytes (Uccelli et al., 2008; Nom-
bela-Arrieta et al., 2011). As reported in Figures 3D–3F,
mesenchymal progenitors lacking HIF factors showed
decreased capacity to differentiate to mesenchymal line-
ages. Specifically, only a few colonies generated by mesen-
chymal progenitors lacking HIF factors differentiated into
adipocytes, whereas the great majority maintained a fibro-
blastic-like morphology (Figure 3D). Similarly, only few
cells lacking expression of HIF factors generated mature
alkaline phosphatase-positive osteoblasts (Figure 3E),
although cell concentrations were similar to control cells
(as reported by crystal violet staining in Figure 3E on the
right). Finally, upon induction of chondrogenesis, mesen-
chymal progenitors lacking HIF factors expressed normal
levels of Col9 (collagenase 9) compared to control cells
but failed to expressCol10 (collagenase 10), thus indicating(C) Morphology of CFU-F colonies of PaS+ cells cultured for 7 days a
independent experiments is shown).
(D) Relative mRNA expression of Nanog, Oct-4, and Sox2 in PaS+ cel
sentative experiment out of two independent experiments performed
(E) SCA-1 and PDGFRa expression in PaS and PaS+ cells (graph on the
colonies are shown on the right (colonies from one out of two indep
(F) Number of colonies recovered from PaS cells or PaS+ cells culture
experiments, mean ± SEM).
(G) RT-PCR of Oct-4, Sox2, and Pdgf mRNA levels in PaS and PaS+ ce
experiment out of two independent experiments performed in triplic
Stethat they may generate immature chondrocytes but not
terminally differentiated chondrocytes (Figure 3F).
In conclusion, these results demonstrate that in PaS+
cells HIF factors are required ex vivo to maintain a mesen-
chymal progenitor state characterized by proliferation,
colony-forming capacity, and competence to differentiate
to multiple mesenchymal lineages.
Expression of HIF-1a and HIF-2a in Mesenchymal
Progenitors Regulates Hematopoiesis
PaS+ cells have been shown to promote HSC proliferation
and maintenance (Morikawa et al., 2009; Nakamura
et al., 2010). Given the profound changes caused by
reduced expression of HIF factors on cell-autonomous
properties of PaS+ cells, we asked whether expression of
HIF factors also modified non-cell-autonomous functions
toward hematopoietic cells. PaS+ mesenchymal progeni-
tors were cocultured in vitro with sorted hematopoietic
stem/progenitor cells (C-KIT+LinSCA-1+ cells, KLS) in
hypoxic conditions for 2 and 4 days (Figure S3A). By first
using control PaS+ cells, we observed that hematopoietic
cells increase in number in the 4 days coculture period
(Figure 4A), and this expansion is accompanied by a
gradual decline in the percentage of KLS cells and hemato-
poietic progenitors (C-KIT+ hematopoietic cells; Figure 4B),
concomitantly with an increase in differentiated hemato-
poietic cells (Lin+ cells; Figure 4B). Upon silencing of
HIF-1a or HIF-2a in PaS+ cells, the total number of
hematopoietic cells (CD45+) recovered after 2 and 4 days
in coculture increased about 2-fold compared to cocultures
with control PaS+ cells (Figure 4C). When analyzing the
relative representation of hematopoietic cells in the cocul-
tures, we found that at day 2 there was no significant
difference in the percentage of KLS, C-KIT+, and Lin+ cells
recovered after silencing of HIF factors (Figures 4B and
4D), thus indicating a 1.5-fold expansion of all hemato-
poietic cells (Figure 4C). Because 90% of hematopoietic
cells in coculture at day 2 are LinC-KIT+ cells (Figures 4B
and 4D), this indicates an expansion of hematopoietic pro-
genitors. Conversely, at day 4 a significant increase in the
percentage of differentiated Lin+ hematopoietic cells was
observed where HIF factors had been silenced in PaS+ cellst 20% or 1% oxygen (one representative experiment out of three
ls cultured for 7 days at 20% or 1% oxygen (data show one repre-
in triplicate with similar results ±SD).
left) after a 7 day culture at 1% oxygen. Representative pictures of
endent experiments are shown).
d at 1% oxygen for 1 week (data are pooled from two independent
lls cultured for 7 days at 1% oxygen (data show one representative
ate with similar results ±SD).
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Figure 3. HIF-1a and HIF-2a Regulate the Biology of Mesenchymal Progenitors
(A) Quantification of CFU-F colonies (left graph) and cell numbers (right graph) from PaS+ cells transduced with shCTR, shHIF-1a, or shHIF-
2a and cultured at 1% oxygen for 7 days (data are pooled from three independent experiments, mean ± SEM).
(B) Morphology of CFU-F colonies generated by PaS+ cells transduced with shCTR, shHIF-1a, or shHIF-2a and cultured at 1% oxygen for
7 days (representative colonies of one out of three independent experiments are shown).
(C) Migration properties of PaS+ cells transduced with shCTR, shHIF-1a, or shHIF-2a and cultured at 1% oxygen; representative pictures of
crystal violet staining are shown on the left, relative quantification is shown on the right (one representative experiment is shown on the
left, whereas data pooled from three independent experiments are shown on the right, mean ± SEM).
(D) Adipogenesis by PaS+ cells transduced with shCTR, shHIF-1a, or shHIF-2a. Representative pictures of adipogenic colonies are shown
on the left; quantification of the adipogenic colonies among the total colonies generated by PaS+ cells is shown on the right (data are
pooled from two independent experiments, mean ± SEM).
(legend continued on next page)
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(Gr1+CD11b+ cells) and CD3+ lymphoid cells (Figures 4F
and S3B) increased, whereas B220 percentages did not
change (data not shown).
In summary, our data indicate that silencing of HIF fac-
tors in mesenchymal progenitors favors early expansion
of hematopoietic progenitors followed by increased dif-
ferentiation. Interestingly, similar results were obtained
when freshly isolated KLS cells were cultured with media
collected from PaS+ cells transduced with shCTR, shHIF-
1a or shHIF-2a: total numbers of CD45+ hematopoietic
cells increased (Figure S3C), and Lin+ cells were more abun-
dant in percentage as well as in total numbers when KLS
were exposed for 4 days to soluble factors released by
PaS+ cells lacking HIF expression (Figure S3D).
To further validate these data, stable forms of HIF-1a and
HIF-2a (mutHIF-1a andmutHIF-2a) were overexpressed in
PaS+ cells and the fate of KLS cells was analyzed after a
4 days coculture. Although the total number of hematopoi-
etic cells did not change upon overexpression of HIF factors
(Figure 4G), the percentage of cells that maintained a he-
matopoietic stem/progenitor expression profile (KLS cells)
was significantly higher upon overexpression HIF factors
in mesenchymal progenitors (Figure 4H), thus denoting
higher maintenance and/or delayed commitment of he-
matopoietic progenitors.
Taken together, these data indicate that HIF-1a and
HIF-2a non-cell-autonomously regulate hematopoiesis
in mesenchymal progenitors by inhibiting the expan-
sion and differentiation of hematopoietic stem/progenitor
cells.
HIF-1a and HIF-2a Inhibit STAT1 Activation in
Mesenchymal Progenitors
To get insights into themolecular circuitry regulated byHIF
factors in PaS+ cells, gene expression profiling was per-
formed upon ex vivo hypoxic culture and HIF-1a or
HIF-2a silencing. Gene set enrichment analysis (GSEA)
(Subramanian et al., 2005) was performed using 3,648
pathway-associated gene sets included in the C2 curated
genes sets of the Molecular Signatures Database (MSigDB
v4.0). Remarkably, the gene sets more enriched upon
downregulation of either gene included interferon-re-
sponding genes (false discovery rate <0.0001) (Figures 5A
and S4A), comprising the transcription factor Stat1, Inter-
feron Regulatory Factors (Irf), and the cytokine Cxcl10
(Figures 5B, S4B, and S4C). Consistently, secretion of(E) Osteogenesis by PaS+ cells transduced with shCTR, shHIF-1a, or sh
quantification of crystal violet staining is shown on the right (data a
(F) Chondrogenic potential of PaS+ cells transduced with shCTR, shHIF
by RT-PCR (data are pooled from two independent experiments, mean
See also Figure S2.
SteCXCL10 into the supernatant was significantly higher
upon silencing of HIF factors (Figure 5C).
HIF-1a was previously reported to inhibit STAT1 expres-
sion through activation of the transcriptional repressor
DEC1/STRA13 in renal carcinoma cells (Ivanov et al.,
2007). Accordingly, silencing of both HIF-1a and HIF-2a
caused reduced Stra13 expression also in mesenchymal
progenitors (Figure 5B), whereas expression of stable forms
of HIF-1a or HIF-2a increased the levels of Stra13 and
decreased those of Cxcl10 (Figure 5D).
In conclusion, the pathway that is most significantly
deregulated by HIF factors in mesenchymal progenitors is
a STAT-interferon pathway that leads to a significant over-
production of cytokines like CXCL10.
STAT1 Expression Downstream HIF Blockade Induces
Hematopoietic Cell Proliferation and Differentiation
To investigate if STAT1 regulated hematopoiesis down-
stream HIF in PaS+ mesenchymal progenitors, STAT1 was
silenced along with HIF factors, and PaS+ cells were cocul-
tured with KLS cells for 4 days. Increased expression of
Stat1 and Cxcl10 was abolished by cosilencing of STAT1
(Figures 6A and 6B), as was the increase in hematopoietic
cell numbers in coculture observed upon silencing of HIF
factors (Figures 6C and 4A). Furthermore, silencing of
STAT1 abrogated hematopoietic differentiation induced
by HIF downregulation in PaS+ cells (Figure 6D). These
data indicate that HIF factors block expression of STAT1
in PaS+ mesenchymal progenitors to prevent proliferation
and differentiation of hematopoietic progenitors in a
non-cell-autonomous manner.
The interferon/STAT pathway has been implicated in
regulating stress-induced hematopoiesis at multiple levels
upon infectious stimuli, by acting directly or indirectly
on HSC to promote demand-driven hematopoiesis (Bal-
dridge et al., 2011; King and Goodell, 2011). Recently,
indications that this pathway may also impact on hemato-
poiesis through non-cell-autonomous regulation of the
HSC niche are beginning to emerge (Takizawa et al.,
2012). Because of the involvement of STAT1 downstream
HIF factors in mesenchymal progenitors in vitro, we asked
whether regulation of HIF factors was also occurring
in vivo, in conditions of hematopoietic expansion upon
infection.Mice were treatedwith poly(I:C) to simulate viral
infection (Sato et al., 2009), and HIF-1a expression was
analyzed in hematopoietic stem/progenitors (KLS cells)
and in PaS+ mesenchymal progenitors. Poly(I:C) treatmentHIF-2a. Representative pictures of ALP+ cells are shown on the left;
re pooled from two independent experiments, mean ± SEM).
-1a, or shHIF-2a. Expression levels of Col9 and Col10 were analyzed
± SEM).
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Figure 4. HIF-1a and HIF-2a in Mesenchymal Progenitors Non-Cell-Autonomously Regulate HSC Maintenance
(A) CD45+ cell numbers at day 2 and day 4 upon coculture of KLS (C-KIT+LinSCA-1+) cells with PaS+ cells (data are pooled from three
independent experiments, mean ± SEM).
(B) Percentage of Lin+, Lin, LinC-KIT+, or KLS cells at day 2 and day 4 upon coculture of KLS cells with PaS+ cells (representative data of
one out of three independent experiments are shown ±SD).
(C) Coculture of KLS cells with PaS+ cells transduced with shCTR, shHIF-1a, or shHIF-2a at day 2 (left) and at day 4 (right). CD45+ cell
numbers are normalized to CD45+ cells obtained from control cocultures (shCTR) (data are pooled from three independent experiments,
mean ± SEM).
(D) Percentage of Lin+, Lin, LinC-KIT+, or KLS cells at day 2 and day 4 upon coculture of KLS cells with PaS+ cells (after HIF-1a silencing
on the left and HIF-2a silencing on the right; representative data of one out of three independent experiments are shown ±SD).
(legend continued on next page)
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HIFs Regulate Bone Marrow Mesenchymal Progenitorsled to increased KLS cell numbers in the BM (Figure 6E, left
panel) and decreased KLS quiescence, as measured by
pyroninY staining (Figure 6E, right panel). Interestingly,
although HIF-1a expression did not change in KLS cells
(Figure 6F), HIF-1a protein levels were significantly reduced
in PaS+ cells upon poly(I:C) (Figure 6G). To understand
whether the reduction of HIF-1a levels was directly caused
by poly(I:C) treatment, isolated PaS+ mesenchymal pro-
genitors were treated with poly(I:C) in vitro. As shown in
Figure 6H, mRNA levels of Hif-1a, Hif-2a and HIF-target
genes (Ca9, Glut-1, and Vegf) were significantly reduced
upon treatment with poly(I:C), wheras Stat1 levels
increased, thus suggesting that HIF factors and HIF-
induced pathways can be directly regulated by infection-
like stimuli in conditions that demand hematopoietic
expansion.DISCUSSION
Anumber of reports have suggested that hypoxia-regulated
pathways participate at various levels in the regulation of
HSC maintenance (Keith and Simon, 2007; Mohyeldin
et al., 2010). It was first demonstrated that the BM is a
hypoxic environment and primitive HSC reside in hypoxic
niches adjacent to endosteal BM regions (Parmar et al.,
2007; Suda et al., 2011). More recently, it was suggested
that HSC are characterized by an intrinsic HIF-dependent
‘‘hypoxic status’’ that does not solely depend on oxygen
concentrations but may be initiated by oxygen-indepen-
dent regulation of HIF-1a (Nombela-Arrieta et al., 2013).
Importantly, genetic evidence points to a very important
role of HIF-1a in promoting HSC maintenance (Ramı´rez-
Bergeron et al., 2004; Takubo et al., 2010), which it exerts
by implementing a glycolytic metabolic checkpoint that
promotes cell quiescence and stem cell capacity (Takubo
et al., 2013).
We investigated the possibility that a ‘‘hypoxic status’’
may characterize not only HSC but also mesenchymal pro-
genitors residing close to HSC in BM niches and exposed
to the same environmental conditions. It was recently(E) Expression of lineage markers at day 2 and day 4 of KLS cells cocult
data of one out of three independent experiments are shown on the lef
experiments, mean ± SEM; cell numbers are normalized over control
(F) Gr1, CD11b, and CD3 expression at day 4 of KLS cells coculture
normalized over control coculture (shCTR); representative data of on
(G) Coculture of PaS+ cells transduced with stable HIF factors (mut HIF
normalized over CD45+ cells obtained from control cocultures (shCTR)
(H) Expression of lineage markers at day 4 upon coculture of KLS cells
experiment out of two independent experiments is shown on the left. G
(shCTR) and pooled from two independent experiments, mean ± SEM
See also Figure S3.
Steshown that low oxygen concentrations promote the
expansion of different types of mesenchymal cells derived
from BM (Haque et al., 2013; Tsai et al., 2012b; Cicione
et al., 2013). However, HIF factors have been proposed to
play different and sometimes opposite roles in the mainte-
nance and differentiation of mesenchymal stem cells,
ranging from block of differentiation to induction of dif-
ferentiation to specific mesenchymal lineages (Hsu et al.,
2013; Hung et al., 2012; Shimba et al., 2004; Wagegg
et al., 2012; Yun et al., 2002). This controversy may derive
from the misleading use of the term mesenchymal stem
cells to define very different cell populations, varying
from cells that simply adhere to the culture dish upon
BM crushing, to very specific cell populations identified
by expression of specific markers (Bianco et al., 2013; Fren-
ette et al., 2013). We analyzed the role of HIF factors in
mesenchymal progenitors expressing SCA-1 and PDGFRa
because these cells reside in periendosteal locations and
regulate HSC maintenance (Morikawa et al., 2009; Naka-
mura et al., 2010). We found that PaS+ endosteal mesen-
chymal progenitors incorporate pimonidazole to higher
levels than other periendosteal stromal cells and express
higher levels of both HIF factors Hif-1a and Hif-2a not
only ex vivo, but also when exposed to similar oxygen
levels in vitro. Also, we demonstrate that PaS+ cells
proliferate and form colonies more efficiently in hypoxic
conditions, which indicates that, although a hypoxic
profile may be intrinsically wired within these cells, low
oxygen cooperates with intrinsic molecular programs to
maintain their identity. These results may have important
implications for optimizing current protocols aimed at ex-
panding mesenchymal progenitors ex vivo for therapeutic
purposes.
Importantly, we found that both HIF factors nonredun-
dantly regulate the morphology and behavior of primary
mesenchymal progenitors: in the absence of HIFa ex-
pression PaS+ mesenchymal progenitors show impaired
proliferation, colony forming ability, and differentiation
and acquire an elongated and motile phenotype. In addi-
tion, HIF factors non-cell-autonomously regulate hemato-
poiesis in mesenchymal progenitors by suppressing theure with PaS+ cells upon HIF-1a or HIF-2a silencing. Representative
t. Graph on the right represents pooled data from three independent
cocultures (shCTR).
with PaS+ cells upon HIF-1a or HIF-2a silencing. Percentages are
e out of two independent experiments are shown ±SD.
-1a or mut HIF-2a) and KLS cells for 4 days. CD45+ cell numbers are
(data are pooled from two independent experiments, mean ± SEM).
with PaS+ cells expressing mutant HIF factors. One representative
raph on the right represents data normalized over control coculture
.
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Figure 5. HIF-1a and HIF-2 a Inhibit Stat1 Activation in Mesenchymal Progenitors
(A) GSEA reveals a significant enrichment in interferon-responsive gene sets in PaS+ cells transduced with shHIF-1a compared to control
cells (shCTR). Browne_interferon_responsive_genes (left panel) and Hecker_IFNB1_targets (right panel) gene sets from MSigDB are shown
upon HIF-1a silencing. The barcode plot indicates the position of the genes belonging to each gene set on the expression data rank sorted
by its association with Hif-1a knockdown, with red and blue colors indicating over- and underexpression in the HIF-1a-silenced group. The
gray scale bar indicates the t statistics, used as weighting score for GSEA analysis.
(B) Relative mRNA expression of Hif-1a, Hif-2a, Stat1, Irf9, Cxcl10, and Stra13 in PaS+ cells transduced with shCTR and shHIF-1a (left
graph) or shCTR and shHIF-2a (right graph). Data show one representative experiment out of two independent experiments performed in
triplicate with similar results ±SD.
(C) Quantification of CXCL10 secretion in the supernatant of PaS+ cells transduced with shHIF-1a or shHIF-2a normalized to CXCL10
released from shCTR PaS+ cells (data are pooled from two independent experiments, mean ± SEM).
(legend continued on next page)
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HIFs Regulate Bone Marrow Mesenchymal Progenitorsproduction of secreted factors that induce hematopoietic
progenitors’ proliferation and differentiation. In line
with our findings, HIF-dependent non-cell-autonomous
regulation of HSC and hematopoiesis had been recently
suggested both for HIF-1a and HIF-2a. For example,
stromal cells residing at the endosteal surface of the BM
were shown to induce HSC maintenance by secreting the
HIF-1a-regulated soluble factor CRIPTO (Miharada et al.,
2011). Moreover, Hif-2a/ mice have hematopoietic
defects also when irradiated and transplanted with wild-
type BM cells, thus underpinning a non-cell-autonomous
role of HIF-2a in the regulation of hematopoiesis (Scortega-
gna et al., 2003).
Mechanistically, we found that HIFa factors regulate
hematopoiesis by limiting activation of interferon/STAT1
responses in mesenchymal progenitors, possibly through
STRA13-induced inhibition of STAT1. Interestingly, it is
recently being shown that in pathological conditions
such as systemic infections, inflammatory signals includ-
ing those generated by interferons promote proliferation
and differentiation of HSC at multiple levels, through
both direct and indirect mechanisms (Schuettpelz and
Link, 2013; Baldridge et al., 2010; King and Goodell,
2011) that include modifying the function of cells
composing the hematopoietic stem cell niche (Takizawa
et al., 2012). In this context, we found that stimuli that
mimic systemic infections and cause HSC expansion sup-
press expression of HIFa factors specifically in mesen-
chymal progenitors, thus providing further indication
that demand-driven hematopoiesis may be mediated by
different cell types within the HSC niche and suggesting
that HIF factors may participate in this regulation.
In summary, our results raise a number of interesting
points: first, they suggest that expression of HIF factors
characterizes specific HSC microenvironments rather
than single cell types, and in these microenvironments
convergent HIF-regulated functionsmay cooperate to regu-
late HSC maintenance and differentiation. Second, they
reinforce the idea that not only hypoxia conditioning,
but also additional factors present in hematopoietic stem
cell niches induce the expression of Hif genes (Nombela-
Arrieta et al., 2013) and indicate that HIF factors may be
importantly regulated at the transcriptional level, although
throughmechanisms not yet identified. Finally, they reveal
that both HIFa subunits are expressed and play similar and
yet nonredundant functions in mesenchymal progenitors.
It will be interesting in the future to understand whether
HIF factors play specific roles in regulating other aspects(D) Relative mRNA expression of Hif-1a, Hif-2a, Cxcl10, and Stra13 in
HIF-1a (left graph) or HIF-2a (right graph). Data show one represent
triplicate with similar results ±SD.
See also Figures S4–S6.
Steof the biology of mesenchymal progenitors that we have
not currently addressed.EXPERIMENTAL PROCEDURES
Mice
C57BL/6J mice were used for all experiments. Animal experiments
were performed in accordance with the guidelines of Beth Israel
Deaconess Medical Center Institutional Animal Care and Use
Committee.
Endosteal Mesenchymal Progenitors Isolation
Endosteal bone surfaces were digested with collagenase II, and
mesenchymal progenitors were isolated and expanded ex vivo as
indicated in Supplemental Experimental Procedures. In selected
experiments, cells were treated with 500 ng/ml poly(I:C) for
16 hr before RNA extraction and analysis.
Pimonidazole Incorporation and Detection
Pimonidazole (HP2-100 Kit) (1.5mg/mouse) was injected intraper-
itoneum, and mice were sacrificed 2 hr after injection (PBS was in-
jected in control mice). For flow-cytometry detection, cells were
stained for surface markers (CD45, Ter119, SCA-1, and PDGFRa)
and then fixed and permeabilized (DB Pharmingen) to allow intra-
cellular pimonidazole detection using antipimonidazole fluores-
cein-isothiocyanate-conjugated antibody.
Lentiviral Vectors
pGIPZ shRNA against HIF-1a and HIF-2a or scrambled shRNA plas-
mids and pDLKO.1 shRNA against Stat1 were purchased from
Open Biosystems. mut HIF-1a, mut HIF-2a vectors were cloned
in third-generation bidirectional lentiviral vector generated in
the laboratory of Dr. Naldini at San Raffaele Scientific Institute
(Amendola et al., 2005).
Isolation of HSC and Coculture with Mesenchymal
Progenitors
Upon crushing of long bones, hematopoietic cells were collected,
filtered, and subjected to red blood cells lysis in ACK lysis buffer
(Gibco); recovered cells were then washed and stained for fluores-
cence-activated cell sorting with anti-CD3, anti-CD8, anti-CD4,
anti-B220, anti-CD11b, anti-Gr1, anti-Ter119 (all biotinylated),
anti-SCA1-PE, and anti-C-KIT-APC (BioLegend). Freshly sorted
HSC cells were seeded on a layer of confluent PaS+ cells in
StemSpan (STEMCELL Technologies) supplemented with 50 ng
TPO and 50 ng SCF at 37C in 1% oxygen concentration. When
cultured with conditioned media derived from PaS+ cells, HSC
cells were maintained in 70% StemSpan supplemented with
50 ng TPO and 50 ng SCF fresh medium and 30% conditioned
medium. All coculture experiments and all cultures withPaS+ cells transduced with CTR plasmid and mutant stable forms of
ative experiment out of two independent experiments performed in
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Figure 6. HIF-1a and HIF-2a Expression in Mesenchymal Progenitors Non-Cell-Autonomously Regulate HSC Maintenance through
STAT1 Inhibition
(A) Relative mRNA expression of Hif-1a (left graph), Stat1 (middle graph), and Cxcl10 (right graph) in PaS+ cells transduced with shCTR or
shHIF-1a either with scrambled shSCR or shSTAT1 (data are pooled from two independent experiments, mean ± SEM).
(B) Relative mRNA expression of Hif-2a (left graph), Stat1 (middle graph), and Cxcl10 (right graph) in PaS+ cells transduced with shCTR or
shHIF-2a either with scrambled shSCR or shSTAT1 (data are pooled from two independent experiments, mean ± SEM).
(legend continued on next page)
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HIFs Regulate Bone Marrow Mesenchymal Progenitorsconditioned media from PaS+ cells have been performed in at least
three independent experiments. Results have been normalized
compared to control conditions and a pool of experiments is
shown in the figures.Statistic
Significance calculation was obtained by Student’s t test: n.s. if not
significant, *p < 0.05, **p < 0.01, ***p < 0.001.
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The data discussed in this publication have been deposited in
NCBI’s Gene Expression Omnibus (Edgar et al., 2002) and are
accessible through GEO Series accession number GSE56141.
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